This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sedlis, S. P. Articles by Schonfeld, G. Search for Related Content PubMed PubMed Citation Articles by Sedlis, S. P. Articles by Schonfeld, G.

Circulation, Vol 73, 978-986, Copyright © 1986 by American Heart Association

ARTICLES

Plasma apoproteins and the severity of coronary artery disease

SP Sedlis, KB Schechtman, PA Ludbrook, BE Sobel and G Schonfeld

Plasma levels of lipids, lipoproteins, and apoproteins in 281 patients undergoing cardiac catheterization were correlated with the incidence and severity of coronary artery disease (CAD) to determine if measurements of apoprotein levels are more predictive of the presence and severity of CAD than the corresponding levels of lipoprotein lipids. In 156 men with CAD among 194 men in the study the only variable other than age that correlated with the severity of CAD, defined by the number of lesions and percent stenosis, was the ratio of apoprotein AI to apoprotein B (r = .1908, p less than .03). The ratio of apoprotein AI to apoprotein B was a more accurate predictor of the severity of CAD than was the ratio of the corresponding high-density to low-density lipoprotein levels (coefficients of partial determination of .07 and .035; p less than .001 and p less than .07, respectively). Multivariate analysis confirmed the independent effect of the ratio of apoprotein AI to apoprotein B on the severity of CAD even after adjustments were made for lipid levels, age, presence of hypertension or diabetes, and therapy with beta-blockers or diuretics. Among men with total occlusion of a coronary artery apoprotein E and apoprotein B levels were significantly higher than in control subjects with a similar extent of CAD (p less than .03). The lipid profiles of the 37 women with CAD were very different from those of the men.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Averina, O. Nilssen, T. Brenn, J. Brox, V. L. Arkhipovsky, and A. G. Kalinin Factors behind the Increase in Cardiovascular Mortality in Russia: Apolipoprotein AI and B Distribution in the Arkhangelsk Study 2000 Clin. Chem., February 1, 2004; 50(2): 346 - 354. [Abstract] [Full Text] [PDF]

				References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]

				S. MacMahon, N. Sharpe, G. Gamble, H. Hart, J. Scott, J. Simes, and H. White Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis : Results of the LIPID Atherosclerosis Substudy Circulation, May 19, 1998; 97(18): 1784 - 1790. [Abstract] [Full Text] [PDF]

				B. Lamarche, S. Moorjani, P. J. Lupien, B. Cantin, P.-M. Bernard, G. R. Dagenais, and J.-P. Despres Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Quebec Cardiovascular Study Circulation, August 1, 1996; 94(3): 273 - 278. [Abstract] [Full Text]

				G. O. Perez, A. J. Mendez, R. B. Goldberg, R. Duncan, A. Palomo, E. DeMarchena, and S.L. Hsia Correlates of Atherosclerosis in Coronary Arteries of Patients Undergoing Angiographic Evaluation Angiology, July 1, 1990; 41(7): 525 - 532. [Abstract] [PDF]

				R. DETRANO and V. FROELICHER A Logical Approach to Screening for Coronary Artery Disease Ann Intern Med, June 1, 1987; 106(6): 846 - 852. [Abstract] [PDF]